"While research on the direct link between GLP-1 agonist diabetes and weight loss drugs and gastroparesis is limited, some studies have shown the potential for gastrointestinal complications with these medications," explains Dr
Expected 12-month results include 15 to 20% body weight loss (35 to 55 pounds for a 250-pound person), 4 to 6 inch waist circumference reduction, dramatic improvement in body shape and clothing fit, and substantial improvement in metabolic health markers
Other more common side effects of Wegovy include gastrointestinal issues like diarrhea and constipation
To survive this "acid bath," the oral GLP-1 contains a specialized buffer that temporarily neutralizes the surrounding stomach acid, creating a protective window just long enough for the pill to pass directly through the stomach lining and into the bloodstream
Side-effect management is highly individual many patients do better with slower titration than the label schedule